from

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

6 months ago

ALCOR Scientific Transforms ESR Testing: Extends Blood Sample Stability from 4 to 28 Hours

Diagnostic Company's iSED Analyzers Deliver Seven-Fold Stability Increase to Improve Accuracy, Efficiency, and Patient Care SMITHFIELD, R.I., Sept. 16, 2025…

6 months ago

From Legacy to Innovation: Morphy Richards Refreshes at IFA 2025

BERLIN, Sept. 15, 2025 /PRNewswire/ -- At IFA 2025, futuristic technologies, robotics, and AI took the spotlight, highlighting the deep integration…

6 months ago

Demand AI Group Secures $2.5 Million in Funding from International Institutional and Local Investors

DENVER, Sept. 12, 2025 /PRNewswire/ -- Demand AI Group Inc. ("Demand AI"), the fast-growing AI-driven B2B marketing and lead-generation company,…

6 months ago

Flipster Secures AAA Security Rating From CER.live, Placing Among Top 13 Most Secure Global Exchanges

PANAMA CITY, Sept. 11, 2025 /PRNewswire/ -- Flipster, a fast-growing crypto perpetuals trading platform, has received an AAA rating from…

7 months ago

XingImaging in partnership with SynuSight was awarded a grant from The Michael J. Fox Foundation to support development of the -synuclein PET tracer 18F-FD4 for Parkinson’s disease

NEW HAVEN, Conn., Sept. 10, 2025 /PRNewswire/ -- XingImaging in partnership with SynuSight Biotech has received funding of $3.84M from…

7 months ago

From Confusion to Clarity: How Fincover Is Cracking the Health Insurance Code for Indian Families in 2025

CHENNAI, India, Sept. 9, 2025 /PRNewswire/ -- In India, a single hospital bill can eat up a decade of savings.…

7 months ago

UltiMaker Introduces Secure Line from the S series, Defense-Grade 3D Printing for High-Security, On-Demand Production

The Secure Line transforms additive manufacturing into a frontline tactical capability across any environment. NEW YORK and GELDERMALSEN, Netherlands, Sept.…

7 months ago

NYSE Content Advisory: Pre-Market Update + S&P 500 enters week 0.8% from record

NEW YORK, Sept. 8, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

7 months ago

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

September 07, 2025 18:25 ET  | Source: Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE)…

7 months ago